Transave Liposomal Technology for Lung Diseases Like Cystic Fibrosis
...lung diseases, is reporting that its lead product candidate, ARIKACE, a liposomal inhalation formulation of amikacin, "may have the ability to penetrate mucus and biofilms, and decrease the number of Pseudomonas aeruginosa lung infections in patients with cystic fibrosis, according to results of a study published in the Journal of...
